Novartis

ICIG to Take Sandoz’ Frankfurt Base

GSK Chief Says UK “Better in EU”

Drug Firms Urge Governments to Fight Superbugs

Recipharm in Ophthalmic Collaboration with Alcon

Roche Wins Patent Dispute Against Cipla

Pfizer to Buy Allergan for $160 Billion

Novartis to Settle With US on Kickback Charges

Topics • Technology

Chances and Hurdles for Biosimilars

Topics • Strategy

Leaving the Patent Cliff Behind

Topics • Strategy

Pharma Players Mostly Lift 2015 Guidance

Topics • Strategy

Significant Value Creation

Novartis and Amgen Partner on Alzheimer’s and Migraine

Novartis Buys Rights to Multiple Sclerosis Drug from GlaxoSmithKline

Aveo Licenses Antibody to Novartis for Treatment of Cachexia

Novartis Can Sell Neupogen Copy in US in September

Novartis Buying US Biotech Company for $200 Million

Perrigo Buying GSK, Novartis Consumer Brands

GSK Chief Witty Questions Pharma M&A Economics

Mylan Said to Prepare Poison Pill Potion Against Teva

Novartis Boosts Cancer Immunotherapy Research Efforts

FDA Approves the First-Ever US Biosimilar

Topics • Strategy

Drugs Industry Battered by Currency and Competition

Arrowhead Buys Novartis’ RNAi R&D Portfolio

Novartis Gets Green Light to Buy GSK Cancer Drugs

Drug Majors’ Venture Capital Funds Back Genetics Start-up

EC Approves Novartis-GSK Asset Swap With Strings

GSK Chief Sees More Unit IPOs as Options

German Watchdog Says Eylea No Better Than Lucentis

Bayer Fails to Block Cancer Generic in India

Novartis’s Gilenya Fails on Primary Progressive MS

Germany's Merck Plans to Expand in Consumer Health

Bayer Closes $14.2 Billion Buy of Merck & Co OTC

Lucentis and Avastin Said to Have Similar Side Effects

New Novartis Heart Drug Seen to Have Enormous Potential

Topics • Strategy

M&A in Chemicals & Pharmaceuticals

159 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.